Novavax Inc (NASDAQ:NVAX)
| 172.49 Delayed Data As of 4:57pm ET |  +0.75 / +0.44%Today’s Change | 16.92 Today|||52-Week Range 331.68 | +54.69% Year-to-Date |
Latest NVAX News | Press Releases
Today’s Trading
| Previous close | 171.74 |
| Today’s open | 156.01 |
| Day’s range | 155.05 - 176.88 |
| Volume | 227,702 |
| Average volume (3 months) | 4,180,941 |
| Market cap | $17.5B |
Data as of 4:57pm ET, 05/06/2021
Growth & Valuation
| Earnings growth (last year) | -31.99% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +2,448.48% |
| P/E ratio | NM |
| Price/Sales | 13.49 |
| Price/Book | 26.80 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMRNBiomarin Pharmaceuti... | +0.90 | +1.16% |
| ZLABZai Lab Ltd | +4.13 | +2.73% |
| TECHBio-Techne Corp | -5.80 | -1.39% |
| CRSPCRISPR Therapeutics ... | -6.09 | -5.35% |
Data as of 4:21pm ET, 05/06/2021
Financials
| Next reporting date | May 11, 2021 |
| EPS forecast (this quarter) | -$3.60 |
| Annual revenue (last year) | $475.6M |
| Annual profit (last year) | -$418.3M |
| Net profit margin | -87.94% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
